Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].

• Witjes JA Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Fred.Witjes@radboudumc.nl.
• Babjuk M Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria.
• Bellmunt J IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain; Harvard Medical School, Boston, Massachusetts, USA.
• Bruins HM Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
• De Reijke TM Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
• De Santis M Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Charité University Hospital, Berlin, Germany.
• Gillessen S Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland; University of Bern, Bern, Switzerland.
• James N University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
• Maclennan S Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
• Palou J Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
• Powles T The Royal Free NHS Trust, London, UK; Barts Cancer Institute, Queen Mary University of London, London, UK.
• Ribal MJ Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Spain.
• Shariat SF Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, New York, USA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
• Van Der Kwast T Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
• Xylinas E Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Paris Descartes University, Paris, France.
• Agarwal N Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, Utah, USA.
• Arends T Urology Department, Canisius-Wilhelmina Ziekenhuis Nijmegen, The Netherlands.
• Bamias A 2nd Propaedeutic Dept of Internal Medicine, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
• Birtle A Division of Cancer Sciences, University of Manchester, Manchester, UK; Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK.
• Black PC Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Colombia, Canada.
• Bochner BH Department of Urology, Weill Cornell Medical College, New York, New York, USA; Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• Bolla M Emeritus Professor of Radiation Oncology, Grenoble-Alpes University, Grenoble, France.
• Boormans JL Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
• Bossi A Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France.
• Briganti A Department of Urology, Urological Research Institute, Milan, Italy; Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy.
• Brummelhuis I Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
• Burger M Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
• Castellano D Medical Oncology Department, 12 de Octubre University Hospital (CIBERONC), Madrid, Spain.
• Cathomas R Departement Innere Medizin, Abteilung Onkologie und Hämatologie, Kantonsspital Graubünden, Chur, Switzerland.
• Chiti A Department of Biomedical Sciences, Humanitas University, Milan, Italy; Humanitas Research Hospital, Milan, Italy.
• Choudhury A Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.
• Compérat E Department of Pathology, Tenon Hospital, HUEP, Paris, France; Sorbonne University, Paris, France.
• Crabb S Cancer Sciences Unit, University of Southampton, Southampton, UK.
• Culine S Department of Cancer Medicine, Hôpital Saint Louis, Paris, France.
• De Bari B Radiation Oncology Department, Centre Hospitalier Régional Universitaire "Jean Minjoz" of Besançon, INSERM UMR 1098, Besançon, France; Radiation Oncology Department, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Lausanne, Switzerland.
• De Blok W Department of Oncological Urology, University Medical Center, Utrecht Cancer Center, Utrecht, The Netherlands.
• De Visschere PJL Department of Radiology and Nuclear Medicine, Division of Genitourinary Radiology and Mammography, Ghent University Hospital, Ghent, Belgium.
• Decaestecker K Department of Urology, Ghent University Hospital, Ghent, Belgium.
• Dimitropoulos K Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
• Dominguez-Escrig JL Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
• Fanti S Department of Nuclear Medicine, Policlinico S Orsola, University of Bologna, Italy.
• Fonteyne V Department of Radiotherapy Oncology, Ghent University Hospital, Ghent, Belgium.
• Frydenberg M Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
• Futterer JJ Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
• Gakis G Department of Urology and Paediatric Urology, University Hospital of Würzburg, Julius-Maximillians University, Würzburg, Germany.
• Geavlete B Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania.
• Gontero P Division of Urology, Molinette Hospital, University of Studies of Torino, Torino, Italy.
• Grubmüller B Department of Urology, Medical University of Vienna, Vienna, Austria.
• Hafeez S Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
• Hansel DE Department of Urology, University of California, San Diego Pathology, La Jolla, California, USA.
• Hartmann A Institute of Pathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany.
• Hayne D Department of Urology, UWA Medical School, University of Western Australia, Perth, Australia.
• Henry AM Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
• Hernandez V Department of Urology, Hospital Universitario Fundación de Alcorcón, Madrid, Spain.
• Herr H Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• Herrmann K Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany.
• Hoskin P Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; Mount Vernon Centre for Cancer Treatment, London, UK.
• Huguet J Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
• Jereczek-Fossa BA Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy.
• Jones R Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
• Kamat AM Department of Urology - Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
• Khoo V Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK; Department of Medicine, University of Melbourne, Australia; Monash University, Melbourne, Australia.
• Kiltie AE CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
• Krege S Department of Urology, Pediatric Urology and Urologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
• Ladoire S Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
• Lara PC Department of Oncology, Hospital Universitario San Roque, Spain; Universidad Fernando Pessoa, Canarias, Spain.
• Leliveld A Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• Linares-Espinós E Department of Urology, University Hospital La Paz, Madrid, Spain.
• Løgager V Department of Radiology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
• Lorch A Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
• Loriot Y Département de Médecine Oncologique, Gustave Roussy, INSERM U981, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
• Meijer R UMC Utrecht Cancer Center, MS Oncologic Urology, Utrecht, The Netherlands.
• Mir MC Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
• Moschini M Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland.
• Mostafid H Department of Urology, Royal Surrey County Hospital, Guildford, UK.
• Müller AC Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany.
• Müller CR Cancer Treatment Centre, Sorlandet Hospital, Kristiansand, Norway.
• N'Dow J Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
• Necchi A Department of Medical Oncology, Istituto Nazionale Tumori of Milan, Milan, Italy.
• Neuzillet Y Department of Urology, Hospital Foch, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.
• Oddens JR Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
• Oldenburg J Department of Oncology, Akershus University Hospital, Lørenskog, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.
• Osanto S Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
• Oyen WJG Department of Biomedical Sciences, Humanitas University, Milan, Italy; Humanitas Research Hospital, Milan, Italy; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
• Pacheco-Figueiredo L Department of Urology, Centro Hospitalar São João, Porto, Portugal; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
• Pappot H Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
• Patel MI Department of Urology, Westmead Hospital, University of Sydney, Sydney, Australia.
• Pieters BR Department Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
• Plass K EAU Guidelines Office, Arnhem, The Netherlands.
• Remzi M Department of Urology, Medical University of Vienna, Vienna, Austria.
• Retz M Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany.
• Richenberg J Department of Imaging and Nuclear Medicine, Royal Sussex County Hospital, Brighton, UK; Brighton and Sussex Medical School, Brighton, UK.
• Rink M Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• Roghmann F Department of Urology, Ruhr-University Bochum, Marien Hospital, Herne, Germany.
• Rosenberg JE Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Weill Cornell Medical College, New York, New York, USA.
• Rouprêt M Department of Urology, Sorbonne Université, GRC n_5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
• Rouvière O Hospices Civils de Lyon, Service d'Imagerie Urinaire et Vasculaire, Hôpital Edouard Herriot, Lyon, France; Université de Lyon, Université Lyon 1, faculté de médecine Lyon Est, Lyon, France.
• Salembier C Department of Radiation Oncology, Europe Hospitals Brussels, Belgium.
• Salminen A Department of Urology, University Hospital of Turku, Finland.
• Sargos P Department of Radiotherapy, Institut Bergonié, Bordeaux, France.
• Sengupta S Department of Surgery, Austin Health, University of Melbourne, Melbourne, Australia; Eastern Health Clinical School, Monash University, Melbourne, Australia.
• Sherif A Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå university, Umeå, Sweden.
• Smeenk RJ Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
• Smits A Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
• Stenzl A Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany.
• Thalmann GN Department of Urology, Inselspital, Bern University Hospital, Bern, Switzerland.
• Tombal B Division of Urology, IREC, Cliniques Universitaires Saint Luc, UCL, Brussels, Belgium.
• Turkbey B Molecular Imaging Program, National Cancer Institute, Bethesda, Maryland, USA.
• Lauridsen SV Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• Valdagni R Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
• Van Der Heijden AG Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
• Van Poppel H Department of Urology, University Hospitals Leuven, Belgium.
• Vartolomei MD Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania.
• Veskimäe E Department of Urology, Tampere University Hospital, Tampere, Finland.
• Vilaseca A Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Spain.
• Rivera FAV Clinica HematoOncologica Bonadona Prevenir, Universidad Metropolitana, Clinica Club de Leones, Barranquilla, Colombia.
• Wiegel T Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
• Wiklund P Icahn School of Medicine, Mount Sinai Health System New York City, New York, USA; Department of Urology, Karolinska Institutet, Stockholm, Sweden.
• Willemse PM Department of Oncological Urology, University Medical Center, Utrecht Cancer Center, Utrecht, The Netherlands.
• Williams A Department of Urology, Auckland City Hospital, Auckland, New Zealand.
• Zigeuner R Department of Urology, Medizinische Universität Graz, Graz, Austria.
• Horwich A Emeritus Professor, The Institute of Cancer Research, London, UK.

Urology